EMA is­sues warn­ing of IVF drug short­age due to man­u­fac­tur­ing is­sues

The Eu­ro­pean Med­i­cines Agency re­cent­ly not­ed the short­age of a drug that is used fre­quent­ly in IVF pro­ce­dures where women have ovar­i­an stim­u­la­tion (i.e. fer­til­i­ty …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER